| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IQV | Common Stock | Award | $0 | +24,141 | +123% | $0 | 43,845 | 06 Feb 2024 | Direct | F1 |
| transaction | IQV | Common Stock | Tax liability | -$2,264,820 | -10,514 | -24% | $215.41 | 33,331 | 06 Feb 2024 | Direct | |
| holding | IQV | Common Stock | 11,893 | 06 Feb 2024 | By Trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IQV | Stock Appreciation Right | Award | $0 | +20,719 | $0 | 20,719 | 07 Feb 2024 | Common Stock | 20,719 | $214.34 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. |
| F2 | Shares held in Ronald E. Bruehlman Revocable Trust. |
| F3 | The stock appreciation right vests in three annual installments beginning on February 7, 2025. |
EVP & Chief Financial Officer